25th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 10-14 December 2002 Update on preclinical and translational research.
The Annual San Antonio Breast Cancer Symposium is one of the largest regular conferences devoted to breast cancer research and treatment. In particular, it provides a forum in which to discuss the more translational aspects of current basic research, and the 2002 meeting was no exception. Growth factor pathways and endocrine resistance, cancer genomics and the clinical applications of proteomics were three of the major topics for discussion. Presentations on genetic susceptibility and the development of prognostic and predictive markers also created much interest.
Head
Julia E
JE
Section of Medicine, Institute of Cancer Research, Sutton, UK. jhead@icr.ac.uk
Ring
Alistair
A
D019313:BRCA1 Protein / Q000235:genetics; D024682:BRCA2 Protein / Q000235:genetics; D001943:Breast Neoplasms / Q000235:genetics* / Q000378:metabolism* / Q000628:therapy; D005260:Female; D023281:Genomics; D006133:Growth Substances / Q000378:metabolism; D006801:Humans; D020543:Proteome; D015398:Signal Transduction
D019313:BRCA1 Protein; D024682:BRCA2 Protein; D006133:Growth Substances; D020543:Proteome